Patients with type 2 diabetes exhibit increased oxidative stress in peripheral blood mononuclear cells, including monocytes; however, the mechanisms remain unknown. r What is the main finding and its importance?
Introduction
One of the characteristic features of type 2 diabetes (T2D) is excessive generation of reactive oxygen species (ROS) in the vasculature, which is thought to play an important role in the pathogenesis of vascular complications associated with diabetes (Wendt et al. 2005; Guzik & Harrison, 2006; Rask-Madsen & King, 2007; Ihm et al. 2009; Folli et al. 2011) . A central source of arterial ROS is derived from immune cells, namely activated monocytes, recruited to the vessel wall (Cathcart, 2004) . Thus, an increased understanding of the precipitating factors and mechanisms underlying the regulation of monocyte ROS production in T2D is warranted.
Patients with T2D exhibit increased markers of endoplasmic reticulum (ER) stress (i.e. 78 kDa glucose regulated protein (GRP78) and CCAAT/-enhancerbinding protein homologous protein (CHOP); Komura et al. 2010; Mozzini et al. 2015) and oxidative stress (Avogaro et al. 2003; Farah et al. 2008; Huang et al. 2011; Cortez-Espinosa et al. 2012; He et al. 2013; Mandal et al. 2013; Paneni et al. 2015) in circulating monocytes and peripheral blood mononuclear cells (PBMCs). A potential mechanism by which monocyte-derived ROS are increased in T2D is ER stress (Lenin et al. 2012) . Although initially a compensatory attempt to maintain cellular homeostasis, sustained ER stress and activation of the unfolded protein response (UPR) are now thought to be the basis of a number of chronic diseases of both metabolic and cardiovascular nature (Eizirik et al. 2008; Hummasti & Hotamisligil, 2010; Hotamisligil, 2010a,b; Gregor & Hotamisligil, 2011; Flamment et al. 2012; Fu et al. 2012; . Hyperglycaemia, hyperinsulinaemia, and hyperlipidaemia are known triggers of ER stress in various tissues and cell types (Wang et al. 2005; Jeffrey et al. 2008; Komura et al. 2010; McAlpine et al. 2010; Mozzini et al. 2015; Rajan et al. 2016; Tampakakis et al. 2016) . For instance, it wa shown that exposure of human monocytes to serum-free medium with high concentrations of glucose plus palmitic acid, a mixture intended to emulate the circulating glucolipotoxic environment of T2D, resulted in the induction of ER stress markers and ROS production (Lenin et al. 2012) .
Alleviation of ER stress can be achieved with the use of chemical chaperones. One such chemical chaperone widely used to alleviate ER stress is tauroursodeoxycholic acid (TUDCA; Ozcan et al. 2006 Ozcan et al. , 2009 Kars et al. 2010; Ceylan-Isik et al. 2011; Achard & Laybutt, 2012; Amin et al. 2012; Galán et al. 2012; Kassan et al. 2012; Kawasaki et al. 2012; Young et al. 2012; Panzhinskiy et al. 2013; Spitler et al. 2013; Ishimura et al. 2014; Vang et al. 2014) , a derivative of the bile acid ursodeoxycholic acid conjugated to a taurine molecule. Although the precise mechanisms by which TUDCA suppresses ER stress remain unknown, it is suggested that this small molecule functions to facilitate protein folding by stabilizing protein-folding intermediates and preventing protein aggregation ; therefore, TUDCA acts upstream of the three primary branches of the UPR. The inhibitory effects of TUDCA on ER stress have been effective in various models of metabolic and cardiovascular diseases (Ozcan et al. 2006 (Ozcan et al. , 2009 Kars et al. 2010; Ceylan-Isik et al. 2011; Achard & Laybutt, 2012; Amin et al. 2012; Galán et al. 2012; Kassan et al. 2012; Kawasaki et al. 2012; Young et al. 2012; Panzhinskiy et al. 2013; Spitler et al. 2013; Ishimura et al. 2014; Vang et al. 2014) . Of clinical relevance, TUDCA can be administered safely to humans (Batta et al. 1982; Peled et al. 1982; Hardison & Grundy, 1984; Panella et al. 1995; Muraca et al. 1995a,b; Portincasa et al. 1996; Setchell et al. 1996; Crosignani et al. 1998; Angelico et al. 1999; Invernizzi et al. 1999; Heubi et al. 2002; Boatright et al. 2009; Kars et al. 2010; Obici et al. 2012; Walsh et al. 2016) and has been shown to produce beneficial metabolic (Kars et al. 2010 ) and vascular effects (Walsh et al. 2016) . For example, we recently reported that acute hyperglycaemia-induced endothelial dysfunction was prevented with oral administration of TUDCA (Walsh et al. 2016) .
Herein, we first tested the hypothesis that freshly isolated PBMCs from T2D patients would exhibit increased ROS compared with those from healthy control subjects. Next, we hypothesized that relative to plasma from healthy control subjects, plasma from T2D patients would increase ROS formation in human monocytes via an NADPH oxidase-dependent mechanism, a primary source of ROS production in PBMCs (Deo et al. 2013 (Deo et al. , 2014 (Deo et al. , 2015 .
Given that there is precedence in the literature for a link between ER stress and activation of NADPH oxidase (Li et al. 2010; Galán et al. 2014) , we further postulated that increased ROS production in response to T2D plasma would be in part attributable to ER stress; that is, we hypothesized that the ER stress inhibitor TUDCA would reduce monocyte NADPH oxidase-derived ROS production caused by T2D plasma. Also, considering the known elevations in plasma glucose and insulin that accompany T2D, we determined whether elevated glucose and insulin, alone or in combination, would increase ROS formation in human monocytes. Lastly, to begin understanding some of the functional implications of these effects, we examined whether T2D plasma-treated monocytes, as well as high-glucose-and/or insulin-treated monocytes, would exhibit increased adhesion to naive endothelial cells and increased lipid uptake, two primary steps in the initiation of atherosclerosis.
Methods

General procedures
Eight patients with T2D (age 57 ± 2 years) and eight age-matched healthy control subjects (age 60 ± 2 years) were recruited for the present study. All experimental procedures and protocols conformed to the Declaration of Helsinki and were approved by the University of Missouri Health Sciences Institutional Review Board. Each subject received a verbal and written explanation of the study objectives, measurement techniques, risks and benefits associated with the investigation. Before participation, each subject provided written informed consent and completed a medical health history questionnaire and a 12 h fasting blood chemistry screening that included a lipid panel, metabolic panel and glycated haemoglobin (HbA 1C ) measurement. On experimental days, subjects arrived at the laboratory in the morning following an overnight fast and without alcohol or physical activity for 24 h. Subjects were positioned supine in a quiet temperature-controlled room (22-23°C) and, after a minimum of 10 min, ß40 ml of blood was obtained from the antecubital vein and collected in sodium heparin tubes for the isolation of peripheral blood mononuclear cells (PBMCs) and plasma.
Protocol 1: primary PBMCs
The purpose of protocol 1 was to compare levels of ROS in PBMCs isolated from T2D patients (n = 8) versus healthy control subjects (n = 8).
Isolation of PBMCs. Primary PBMCs were freshly isolated from whole blood with density gradient centrifugation using Histopaque (Sigma, St Louis, MO, USA) at 600g for 30 min at room temperature followed by three washes in sterile Dulbecco's phosphate-buffered saline solution (PBS; Invitrogen, Life Technologies, Grand Island, NY, USA). Cells were counted using the Trypan Blue (Sigma) exclusion method (Strober, 2001 ) to quantify cell counts before and after protocols.
Detection of intracellular ROS in freshly isolated PBMCs.
Basal ROS measurements were performed on freshly isolated primary PBMCs immediately upon isolation ex vivo to prevent any artificial increase in ROS production. Primary PBMCs (ß1.5 × 10 6 ) were incubated with 5 μM dihydroethidium (DHE; Life Technologies, Carlsbad, CA, USA) for 60 min at 37°C, and ROS fluorescence was determined using a fluorescent plate reader (Spectramax M2; Molecular Devices, Sunnyvale, CA, USA) at 544 and 612 nm excitation and emission wavelengths, respectively, as previously performed (Deo et al. 2013 (Deo et al. , 2014 (Deo et al. , 2015 . Background fluorescence intensity, obtained from blank wells, was subtracted from every well that received DHE. Although DHE is a widely used sensitive superoxide probe, DHE oxidation yields at least two fluorescent products, 2-hydroxyethidium, known to be more specific for superoxide, and the less-specific product ethidium (Fink et al. 2004; Fernandes et al. 2007; Zielonka & Kalyanaraman, 2010) . Accordingly, the use of the term ROS may be more appropriate than the use of the term superoxide (Kalyanaraman, 2011) . Nevertheless, using the DHE methodology, we and others have shown that the superoxide dismutase mimetic (tempol) and inhibitors of NADPH oxidase (diphenylene iodonium, apocynin and gp91ds-tat) reduce the DHE fluorescence signal (Jenkins et al. 2011a,b; Deo et al. 2013) , indicating that the differences we are reporting here are mainly related to differences in superoxide production. Data are expressed as the fold change from PBMC measurements made in control subjects. The purpose of protocol 2 was to examine the influence of T2D plasma on monocyte-derived ROS, monocyte-endothelial cell adhesion and lipid uptake, and to determine whether ER stress and NADPH oxidase are involved in mediating these effects.
Cell culture and cellular treatments. For this protocol, a subset of subjects from protocol 1 returned to the laboratory for a second blood draw (ß60 ml). The plasma from healthy control subjects (n = 4) and T2D patients (n = 5) was pooled within each group for cellular treatments. Pooled plasma from control subjects contained 83 mg dl THP-1 cells, a human monocyte cell line (American Type Culture Collection), were grown in media enriched with nutrients (RPMI 1640; Invitrogen, Life Technologies, Grand Island, NY, USA; 11 mM glucose) and 10% fetal bovine serum at 37°C. Once an adequate total number of cells were grown, they were harvested, plated in 96-well plate and incubated in RPMI 1640 media devoid of nutrients in serum-starved conditions containing 0.5% fetal bovine serum for 30 h. Subsequently, the cells were treated with plasma from T2D patients or healthy control subjects (30% of final experimental volume) for 36 h. Phosphate-buffered saline provided plasma-free control conditions. To determine whether NADPH oxidase and ER stress are involved in mediating monocyte ROS production, changes in gene expression, endothelial cell adhesion and foam cell formation, monocytes were treated with gp91ds-tat (1 μM; an NADPH oxidase inhibitor; Rey et al. 2001) and TUDCA (500 μg ml −1 ; an ER stress inhibitor; Ozcan et al. 2006; Berger & Haller, 2011; Galán et al. 2012; Kassan et al. 2012; Kawasaki et al. 2012; Young R. M. Restaino and others et al. 2012; Dromparis et al. 2013 ) alone, or both in combination, also for 36 h. The effects of gp91 ds-tat (1 μM) and TUDCA (500 μg ml −1 ) treatments for 36 h on ROS levels in normal (i.e. non-stimulated) monocytes were also examined. In such experiments, vehicle (sterile water) was used as the control treatment. In addition, the effects of high glucose (22 mM) and high insulin (100 nM), alone or in combination, for 36 h on ROS levels and monocyte-endothelial cell adhesion were examined, using concentrations of glucose and insulin that are similar to those used in previous cell culture studies (Iida et al. 2002; Montagnani et al. 2002; Sheikh-Ali et al. 2010; Schisano et al. 2011; Yun et al. 2012) . Lastly, tunicamycin (TUNICA; 5 μg ml −1 ) was used as an ER stress inducer (Gargalovic et al. 2006; Ozcan et al. 2009; Hua et al. 2010; Berger & Haller, 2011; Li et al. 2011; Chen et al. 2012; Kassan et al. 2012) to delineate further the role of ER stress in mediating monocyte ROS production and endothelial cell adhesion. In such experiments, vehicle (sterile water) was also used as control treatment. For all experiments performed, eight wells were used per treatment condition.
Detection of intracellular ROS in monocytes following
treatments. THP-1 cells (ß1 × 10 6 per well) were incubated with 5 μM dihydroethidium (DHE; Life Technologies, Carlsbad, CA, USA) and treatments in a final volume of 300 μl serum-starved media for 60 min at 37°C. ROS fluorescence was measured on a fluorescent plate reader using excitation and emission filters of 544 and 612 nm, respectively.
Assessment of gene expression by real-time RT-PCR.
Briefly, ß1 × 10 6 THP-1 cells per well were plated in 24-well plates to determine the effect of plasma from T2D patients versus control subjects on gene expression in human monocytes. Total RNA was extracted using QIAmp RNA Blood Mini kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. Subsequently, total RNA was reverse transcribed using an A5300 kit (Promega, Fitchburg, WI, USA), and 5 ng of cDNA from each sample was then assayed for the determination of gene expression. Messenger RNA levels of NADPH oxidase subunit genes (gp91 phox and p67 phox ), inflammatory genes (NFκB), and ER stress genes (CHOP and GRP78) were then determined using gene-specific primers and Taqman chemistry (Taqman Gene Expression assays, Life Technologies, Grand Island, NY, USA). Real-time PCR was performed using a CFX95 Real Time PCR system (BioRad, Hercules, CA, USA), and the data are presented as 2 C t mean ± SEM values ( C t = 18S rRNA C t − gene of interest C t ). Data were normalized to 18S rRNA as a reference gene, and were presented relative to the normalized value for the treatment with control plasma.
Determination of monocyte-endothelial cell adhesion.
After the 36 h treatments, ß1 × 10 6 THP-1 cells were washed with sterile PBS in order to remove any residual treatment. Cells were then co-incubated with naive cultured human umbilical vein endothelial cells (HUVECs; American Type Culture Collection) at 37°C for 60 min in a 96-well plate. Washing of THP-1 cells prior to co-incubation ensured that HUVECs were never exposed to the experimental treatments. Monocyte-endothelial cell adhesion was performed using a commercially available leucocyte cell adhesion assay kit (Cell Biolabs, Inc., San Diego, CA, USA), as previously performed (Deo et al. 2013) . The cellular mixture was washed with serum-free media and the non-adherent cells were removed. The plate was read on a fluorescent plate reader using excitation and emission filters of 480 and 520 nm, respectively.
Determination of monocyte-derived foam cell formation by assessment of LDL uptake and LDL receptor expression. Briefly, ß3 × 10 4 THP-1 cells per well were plated in 96-well plates according to the manufacturer's instructions (Cayman Chemicals, Ann Arbor, MI, USA). After treatments, LDL conjugated to a fluorescent probe (DyLight 550) was incubated with cells for 3.5 h to detect LDL uptake into cultured cells. Fluorescence was measured on a fluorescent plate reader using excitation and emission filters of 540 and 570 nm, respectively. Subsequently, these cells were stained for LDL receptor density using primary LDL receptor-specific antibody and DyLight 488-conjugated secondary antibody. Fluorescence was determined qualitatively using a fluorescent microscope and quantified using a fluorescent plate reader with excitation and emission filters of 485 and 535 nm, respectively.
Statistical analysis
Statistical analyses were conducted using SigmaStat (Jandel Scientific Software, SPSS, Itasca, IL, USA) software for Microsoft Windows. All results are presented as means ± SD. Student's paired t tests were used to compare T2D patients and control subjects when appropriate. Treatment differences were analysed using one-way ANOVA. When a main effect was obtained, Fisher's least significant differences post hoc test was performed. All tests were two sided, and a P value of <0.05 was considered statistically significant.
Results
Characteristics of all study participants are summarized in Table 1 . As expected, fasting glucose and HbA 1c measures were higher in the T2D patients. The PBMCs isolated from 
Values are means ± SD. Abbreviation: T2D, type 2 diabetes. * P < 0.05 versus control subjects.
T2D patients displayed higher intracellular ROS, relative to control subjects (P < 0.05; Fig. 1 ).
As illustrated in Fig. 2 , exposure of monocytes to T2D plasma resulted in increased ROS production when compared with monocytes exposed to plasma from control subjects (P < 0.05). It should be noted that even control plasma induced a significant increase in ROS production when compared with monocytes treated with PBS as a plasma-free control, suggesting that factors carried in plasma can induce ROS production by monocytes and that this production is greater when plasma is from patients with T2D (control plasma fold change from PBS, 2.18 ± 0.19; T2D plasma fold change from PBS, 2.80 ± 0.18; P < 0.05). The T2D plasma-induced ROS production was abrogated by treatment of THP-1 cells with gp91ds-tat (NADPH oxidase inhibitor), TUDCA (ER stress inhibitor) or a combination of both (P < 0.05 versus T2D plasma), which brought the levels of ROS below the levels of ROS generated by control plasma.
When THP-1 cells were exposed to high glucose (22 mM), high insulin (100 nM) or both combined, monocyte ROS production was also increased (P < 0.05) as shown in Fig. 3 . In addition, similar results to those obtained by treating cells with T2D plasma were found when cells were exposed to an ER stress inducer (TUNICA; Fig. 4 ). We also examined the effect of gp91ds-tat and TUDCA on ROS levels in non-stimulated monocytes. We found that ROS levels were decreased with gp91 ds-tat and TUDCA by 11.8 ± 3.4 and 19.2 ± 3.9% (P < 0.05), respectively, suggesting that THP-1 cells exhibit a tonic level of ROS production and these compounds are effective in reducing ROS.
As shown in Fig. 5 , gp91 phox and p67 phox , as well as GRP78 and CHOP mRNA (ER stress markers) were increased in monocytes exposed to plasma from T2D patients versus R. M. Restaino and others control subjects (P < 0.05). The T2D plasma-induced upregulation of these genes was eliminated by treatment of cells with TUDCA or a combination of TUDCA and gp91ds-tat (P < 0.05 versus T2D plasma).
Monocytes exposed to plasma from T2D patients exhibited increased adherence to naive endothelial cells, relative to monocytes exposed to plasma from control subjects (P < 0.05; Fig. 6 ). The T2D plasma-induced monocyte-endothelial adherence was abolished only by treatment of monocytes with the combination of TUDCA and gp91ds-tat (P < 0.05 versus T2D plasma). Although treatment of monocytes with TUDCA alone tended to 
. Mean data showing intracellular ROS production in human monocytes (THP-1 cells) following treatment with T2D plasma with or without gp91ds-tat (an NADPH oxidase inhibitor) and TUDCA [an endoplasmic reticulum (ER) stress inhibitor] alone or in combination
Data are expressed as the fold difference from control plasma. Values are means ± SD (n = 8 per condition). * P < 0.05 versus control plasma. † P < 0.05 versus T2D plasma. decrease endothelial cell adherence, this effect was not statistically significant (T2D plasma versus T2D plasma + TUDCA, P = 0.07). Monocyte-endothelial cell adherence was also increased when monocytes were treated with high glucose, high insulin or both combined (P < 0.05; Fig. 7 ).
As summarized in Fig. 8A , monocytes exposed to plasma from T2D patients exhibited increased LDL uptake when compared with monocytes exposed to plasma from control subjects (P < 0.05). The T2D plasma-induced LDL uptake was abrogated by treatment 
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of cells with gp91ds-tat, TUDCA or a combination of both (P < 0.05 versus T2D plasma). Likewise, LDL receptor density was increased in monocytes exposed to T2D versus control plasma (P < 0.05; Fig. 8B ). Although T2D plasma-induced LDL receptor density was decreased by treatment of cells with gp91ds-tat and TUDCA (P < 0.05 versus T2D plasma), this effect did not reach statistical significance with the combined treatment.
The experimental concentrations of gp91ds-tat and TUDCA used in the above experiments had no effect on cell viability as assessed by the Trypan Blue exclusion method (gp91dsTAT, 146 × 10 4 cells ml −1 ; TUDCA, 145 × 10 4 cells ml −1 ; combination treatment, 147 × 10 4 cells ml −1 ; and vehicle: 146 × 10 4 cells ml −1 ).
Discussion
The primary novel finding of the present study was that increased oxidative stress in PBMCs isolated from patients with T2D could be recapitulated, in part, in cultured human monocytes exposed to plasma from T2D patients. Likewise, monocyte ROS production and endothelial cell adhesion were increased with high-glucose and high-insulin treatment alone and in combination. Furthermore, we provided evidence that increased ROS formation in human monocytes treated with T2D plasma was NADPH oxidase derived and led to increased endothelial cell adhesion and lipid uptake. Notably, we also found that T2D plasma-induced monocyte ROS and downstream functional effects were abolished by treating cells with TUDCA, a chemical chaperone known to inhibit ER stress and available for human use. Collectively, these data suggest that excess monocyte ROS associated with T2D can be attributed, in part, to signals from the circulating environment and that an interplay between ER stress and NADPH oxidase activity may be a mechanism mediating endothelial cell adhesion and foam cell formation in T2D.
In the present study, we found that PBMCs isolated from patients with T2D exhibited elevated ROS. Although the underlying cause of this link between T2D and monocyte ROS remains largely unknown, it has been proposed that factors from the circulating milieu are responsible for the induction of monocyte ROS in T2D (Jain et al. 2007; Huang et al. 2011; Lenin et al. 2012) . A candidate is hyperglycaemia, as many studies now demonstrate that high glucose causes increased expression of NADPH oxidase and subsequent ROS production in various cell types, including monocytes (Jain et al. 2007; Kuppan et al. 2010; Rodiño-Janeiro et al. 2010; Huang et al. 2011; Maeda et al. 2015; Nagasu et al. 2016) . However, other factors are likely to be involved. Values are means ± SD (n = 8 per condition). * P < 0.05 versus control plasma. † P < 0.05 versus T2D plasma. The difference between T2D plasma and T2D plasma + TUDCA was trending but did not reach statistical significance (P = 0.07).
In this regard, it has been shown that exposure of human monocytes to high levels of glucose plus palmitic acid, a cocktail mimicking the circulating glucolipotoxic environment of T2D, induces ROS formation (Lenin et al. 2012) . Importantly, we now demonstrate that plasma from T2D patients promotes ROS generation in human monocytes, further strengthening the hypothesis that increased monocyte ROS in T2D can be, in part, attributed to signals originating from the circulating environment, such as high glucose and insulin. Indeed, although other factors cannot be ruled out, in separate experiments the treatment of monocytes with high glucose and high insulin, alone or in combination, increased ROS. Excessive ROS generation in monocytes is thought to be a crucial factor in the initiation and progression of multiple diabetic complications, including cardiovascular disease (Cathcart, 2004) . Indeed, it is well established that activated circulating monocytes are recruited to the vessel wall and differentiated into macrophages (Cathcart, 2004) . Infiltrated immune cells into the artery wall are a rich source of ROS and contribute to the development of endothelial dysfunction and atherosclerosis (Cathcart, 2004) . Among the multiple sources of ROS, NADPH oxidase is considered to be the main enzymatic source of ROS in monocytes (Barbieri et al. 2003; Cathcart, 2004; Furukawa et al. 2004) , and its activity has been shown to be elevated in T2D (Avogaro et al. 2003; Huang et al. 2011) . A novel finding of the present study was that while treatment of monocytes with T2D plasma increased ROS generation, inhibition of NADPH oxidase with gp91ds-tat eliminated this induction. Consistent with the hypothesis that NADPH oxidase-derived ROS play an important role in the development of cardiovascular disease, mice lacking components of the NADPH oxidase subunits, when crossed to the apoE −/− background, have a marked reduction in arterial ROS production, enhanced nitric oxide bioavailability, and reduced formation of atherosclerotic lesions (Barry-Lane et al. 2001; Judkins et al. 2010) .
Although the molecular mechanisms linking the circulating milieu of T2D and monocyte ROS formation remain largely unknown, PBMCs and monocytes isolated from T2D patients and insulin-resistant subjects exhibit markers of ER stress (Komura et al. 2010; Sage et al. 2012; Mozzini et al. 2015) and oxidative stress (Avogaro et al. 2003; Huang et al. 2011) . Here, we built on these previous findings by demonstrating that T2D plasma induces expression of the ER stress markers CHOP and GRP78 in monocytes, and this effect is accompanied by increased ROS formation. Importantly, treatment of monocytes with TUDCA, an ER stress inhibitor, abolished T2D plasma-induced ROS. Reciprocally, we found that pharmacological induction of ER stress in monocytes using TUNICA, a broad ER stress inducer, led to increased ROS, and this finding is consistent with data from others (Lenin et al. 2012) . Interestingly, 
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although gp91ds-tat and TUDCA both inhibited ROS production with T2D plasma, an additive or synergistic effect on suppression of ROS was not found, suggesting redundancy in the mechanisms of action or a causal link between ER stress and NADPH oxidase activity. Given that pharmacological induction of ER stress also led to increased ROS formation in monocytes, and that this response was abrogated with NADPH oxidase inhibition, ER stress appears to be upstream to the increase in NADPH oxidase-derived ROS. In support of this concept, previous studies have implicated CHOP, the downstream transcription factor of the PKR-like endoplasmic reticulum kinase (PERK) branch of the UPR, as the mediator of ROS production induced by TUNICA (Gorlach et al. 2006; Santos et al. 2009 ). Although there is evidence in the literature supporting the notion that ER stress can cause increased NADPH oxidase activity (Li et al. 2010; Galán et al. 2014) , we cannot rule out the possibility that T2D plasma-induced NADPH oxidase-derived ROS also contributed to ER stress. Indeed, we found that induction of GRP78, a common ER stress marker, in monocytes treated with T2D plasma, was normalized with inhibition of NADPH oxidase. The downregulation of GRP78 with gp91ds-tat is consistent with evidence suggesting that the link between ER stress and oxidative stress can lead to a vicious cycle (Malhotra & Kaufman, 2007) . That is, ER stress can induce ROS production, which subsequently exacerbates the existing imbalance in ER homeostasis. Collectively, these findings highlight that factors contained within the plasma of T2D patients can contribute to increased oxidative stress in monocytes, and these effects are largely mediated by the interaction between ER stress and NADPH oxidase activity. However, while our data suggest a potential link between ER stress and activation of NADPH oxidase, additional research is necessary to delineate this mechanism of action precisely and discern which specific branch of the UPR is primarily activated in monocytes from T2D patients. The relevance of these findings was substantiated by the observation that exposure of monocytes to T2D plasma, high glucose, high insulin or the combination of high glucose and insulin resulted in increased adhesion to naive endothelial cells. Interestingly, in T2D plasma-treated monocytes, we found that TUDCA and gp91ds-tat, when added alone, were insufficient to ameliorate the increased endothelial cell adhesion significantly. However, treatment of monocytes with both compounds combined fully eliminated the increased adhesion to endothelial cells, suggesting that ER stress and increased NADPH oxidase activity interact to promote monocyte-endothelial cell adherence. Notably, our data suggest, for the first time, that hyperglycaemia and hyperinsulinaemia may contribute to increased 'stickiness' of monocytes, independent of endothelial dysfunction or inflammation. This finding has important implications for our understanding of the nexus between T2D and cardiovascular disease. Indeed, adhesion of monocytes to the endothelium is one of the early events in the development of endothelial dysfunction and atherosclerosis (Ikeda et al. 1998; Mestas & Ley, 2008) .
Another salient finding of the present study was the observation that treatment of monocytes with T2D plasma promoted an increase in LDL uptake, and this was likely to be mediated by an increased expression of LDL receptors. Of significance, inhibition of ER stress and NADPH oxidase activity, alone and in combination, fully nullified the increase in lipid uptake by monocytes treated with T2D plasma. The finding that ER stress contributes to lipid uptake in THP-1 cells has already been proposed (Hua et al. 2010) , and the present data support the idea that this phenomenon is ROS dependent. Nevertheless, more research is needed to determine the mechanisms by which superoxide radicals are implicated in direct lipid and lipoprotein oxidation reactions, leading to foam cell formation and atherogenesis (Cathcart, 2004; Liang et al. 2007) .
Despite the novel findings reported herein, some limitations warrant discussion. One such limitation to be acknowledged is the lack of ER stress measures in PBMCs isolated from T2D patients compared with healthy control subjects. However, the finding that ER stress manifests in monocytes and PBMCs from patients with T2D has been shown by others (Komura et al. 2010; Mozzini et al. 2015) . Our study aimed to build upon these earlier findings, and we now reveal the intriguing observation that the circulating milieu of T2D is capable of inducing monocyte ROS production and that ER stress is implicated in this response. In addition, although these data indicate that plasma from T2D subjects promotes monocyte ROS formation, endothelial cell adhesion and lipid uptake, the factors responsible for these effects remain incompletely understood. The finding that exposure of monocytes to high glucose and high insulin alone and in combination resulted in an increased production of ROS and endothelial cell adhesion suggests that glucose and insulin may be two of the factors mediating the effects of T2D plasma. However, given the number of factors in circulating plasma, additional studies are needed to identify other potential contributors and their potential interactions with glucose and insulin.
In conclusion, this study suggests that excess monocyte ROS production associated with T2D can be, in part, attributed to signals from the circulating environment. Furthermore, these data support the existence of an interplay between ER stress and NADPH oxidase activity as an underlying mechanism mediating excess monocyte ROS generation, endothelial cell adhesion and lipid uptake in T2D. 
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